A randomised, placebo-controlled, dose-rising study in healthy males volunteers to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of SVT-40776, a novel selective M3 antimuscarinic
Viayna C1, Alvarez D 1, López R1, Sanagustín J1, Lagunas C1 1. Laboratorios SALVAT, S.A
|
|
Abstract 270
|
|
|
Non Discussion Posters:
Scientific Non Discussion Poster Session 19
|
|
|